The hepatic expression of NF-κB and p38 was higher in the livers of patients with NASH than in the livers of patients without NASH and decreased after NASH remission (Figure 2b and Figure S1c). This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatohepatitis.